Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.02
THC's Cash to Debt is ranked lower than
52% of the 302 Companies
in the Global Medical Care industry.

( Industry Median: 0.19 vs. THC: 0.02 )
THC' s 10-Year Cash to Debt Range
Min: 0   Max: 0.35
Current: 0.02

0
0.35
Equity to Asset 0.04
THC's Equity to Asset is ranked higher than
50% of the 303 Companies
in the Global Medical Care industry.

( Industry Median: 0.41 vs. THC: 0.04 )
THC' s 10-Year Equity to Asset Range
Min: 0   Max: 0.45
Current: 0.04

0
0.45
Interest Coverage 1.40
THC's Interest Coverage is ranked higher than
55% of the 194 Companies
in the Global Medical Care industry.

( Industry Median: 5.06 vs. THC: 1.40 )
THC' s 10-Year Interest Coverage Range
Min: 0.64   Max: 6.4
Current: 1.4

0.64
6.4
F-Score: 4
Z-Score: 1.21
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 4.62
THC's Operating margin (%) is ranked higher than
66% of the 305 Companies
in the Global Medical Care industry.

( Industry Median: 8.59 vs. THC: 4.62 )
THC' s 10-Year Operating margin (%) Range
Min: -13.24   Max: 15.05
Current: 4.62

-13.24
15.05
Net-margin (%) -0.45
THC's Net-margin (%) is ranked higher than
62% of the 305 Companies
in the Global Medical Care industry.

( Industry Median: 4.91 vs. THC: -0.45 )
THC' s 10-Year Net-margin (%) Range
Min: -26.62   Max: 13.5
Current: -0.45

-26.62
13.5
ROE (%) -9.69
THC's ROE (%) is ranked higher than
56% of the 286 Companies
in the Global Medical Care industry.

( Industry Median: 9.56 vs. THC: -9.69 )
THC' s 10-Year ROE (%) Range
Min: -124.98   Max: 94.78
Current: -9.69

-124.98
94.78
ROA (%) -0.48
THC's ROA (%) is ranked higher than
62% of the 306 Companies
in the Global Medical Care industry.

( Industry Median: 3.52 vs. THC: -0.48 )
THC' s 10-Year ROA (%) Range
Min: -23.6   Max: 13.89
Current: -0.48

-23.6
13.89
ROC (Joel Greenblatt) (%) 9.42
THC's ROC (Joel Greenblatt) (%) is ranked higher than
67% of the 305 Companies
in the Global Medical Care industry.

( Industry Median: 18.24 vs. THC: 9.42 )
THC' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -22.25   Max: 38.61
Current: 9.42

-22.25
38.61
Revenue Growth (%) 21.80
THC's Revenue Growth (%) is ranked higher than
93% of the 239 Companies
in the Global Medical Care industry.

( Industry Median: 6.10 vs. THC: 21.80 )
THC' s 10-Year Revenue Growth (%) Range
Min: -13.3   Max: 34.9
Current: 21.8

-13.3
34.9
EBITDA Growth (%) 6.80
THC's EBITDA Growth (%) is ranked higher than
76% of the 191 Companies
in the Global Medical Care industry.

( Industry Median: 6.50 vs. THC: 6.80 )
THC' s 10-Year EBITDA Growth (%) Range
Min: -68.5   Max: 117.8
Current: 6.8

-68.5
117.8
» THC's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q4 2013

THC Guru Trades in Q4 2013

Paul Tudor Jones 5,600 sh (New)
Larry Robbins 13,812,831 sh (+38.14%)
Ray Dalio 21,729 sh (+31.91%)
Vanguard Health Care Fund 1,400,000 sh (unchged)
John Griffin Sold Out
David Tepper Sold Out
Jeremy Grantham 11,743 sh (-41.4%)
Jim Simons 63,075 sh (-74.54%)
Steven Cohen 13,913 sh (-93.33%)
» More
Q1 2014

THC Guru Trades in Q1 2014

Manning & Napier Advisors, Inc 220,380 sh (New)
Louis Moore Bacon 8,988 sh (New)
Mario Gabelli 15,000 sh (New)
Steven Cohen 21,789 sh (+56.61%)
Ray Dalio 33,400 sh (+53.71%)
Vanguard Health Care Fund 1,400,000 sh (unchged)
Larry Robbins 13,812,831 sh (unchged)
Jeremy Grantham Sold Out
Paul Tudor Jones Sold Out
Jim Simons Sold Out
» More
Q2 2014

THC Guru Trades in Q2 2014

George Soros 22,150 sh (New)
Louis Moore Bacon 154,841 sh (+1622.75%)
Larry Robbins 13,812,831 sh (unchged)
Manning & Napier Advisors, Inc 220,380 sh (unchged)
Vanguard Health Care Fund 1,400,000 sh (unchged)
Mario Gabelli 15,000 sh (unchged)
Ray Dalio 14,725 sh (-55.91%)
» More
Q3 2014

THC Guru Trades in Q3 2014

Jim Simons 68,475 sh (New)
Ken Heebner 1,965,000 sh (New)
Louis Moore Bacon 162,451 sh (+4.91%)
Vanguard Health Care Fund 1,460,000 sh (+4.29%)
Larry Robbins 13,812,831 sh (unchged)
Ray Dalio Sold Out
George Soros Sold Out
Manning & Napier Advisors, Inc 187,190 sh (-15.06%)
Mario Gabelli 10,000 sh (-33.33%)
» More
» Details

Insider Trades

Latest Guru Trades with THC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Ken Heebner 2014-09-30 New Buy3.3%$44.97 - $63.27 $ 48.23-14%1965000
George Soros 2014-09-30 Sold Out 0.01%$44.97 - $63.27 $ 48.23-14%0
Ray Dalio 2014-09-30 Sold Out 0.01%$44.97 - $63.27 $ 48.23-14%0
Mario Gabelli 2014-09-30 Reduce -33.33%$44.97 - $63.27 $ 48.23-14%10000
George Soros 2014-06-30 New Buy0.01%$38.75 - $49.47 $ 48.237%22150
Ray Dalio 2014-06-30 Reduce -55.91%0.01%$38.75 - $49.47 $ 48.237%14725
Ray Dalio 2014-03-31 Add 53.71%$38.9 - $48.33 $ 48.239%33400
Mario Gabelli 2014-03-31 New Buy$38.9 - $48.33 $ 48.239%15000
John Griffin 2013-12-31 Sold Out 1.5%$39.81 - $48.26 $ 48.2311%0
David Tepper 2013-12-31 Sold Out 0.14%$39.81 - $48.26 $ 48.2311%0
Ray Dalio 2013-12-31 Add 31.91%$39.81 - $48.26 $ 48.2311%21729
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Top Ranked Articles about Tenet Healthcare Corp

Gabelli and Robbins Highlight Guru Buys of the Week
The following information is a highlight of the real-time guru activity we saw this week. To view more information on these gurus, check out their guru portfolios. The “Real Time Picks” reports the stock purchases and sells that Gurus have made within the prior two weeks. If a Guru makes a purchase or sell of a company in which they own a greater-than 5% stake, SEC regulations require them to report their transaction within two days. This week we saw notable increases in Real Time activity from Mario Gabelli and Larry Robbins. Read more...
Larry Robbins Ups Holdings in Health Care Company
Yesterday GuruFocus Real Time Picks reported two guru buys coming from Larry Robbins into the company Tenet Healthcare (THC). The guru made these two buys on two different days over the past week. Read more...

Ratios

vs
industry
vs
history
P/B 6.45
THC's P/B is ranked higher than
58% of the 326 Companies
in the Global Medical Care industry.

( Industry Median: 2.96 vs. THC: 6.45 )
THC' s 10-Year P/B Range
Min: 1.09   Max: 101.5
Current: 6.45

1.09
101.5
P/S 0.29
THC's P/S is ranked higher than
95% of the 326 Companies
in the Global Medical Care industry.

( Industry Median: 1.55 vs. THC: 0.29 )
THC' s 10-Year P/S Range
Min: 0.05   Max: 0.72
Current: 0.29

0.05
0.72
EV-to-EBIT 21.48
THC's EV-to-EBIT is ranked higher than
74% of the 326 Companies
in the Global Medical Care industry.

( Industry Median: 22.71 vs. THC: 21.48 )
THC' s 10-Year EV-to-EBIT Range
Min: -125.6   Max: 30.4
Current: 21.48

-125.6
30.4
Shiller P/E 28.85
THC's Shiller P/E is ranked higher than
86% of the 326 Companies
in the Global Medical Care industry.

( Industry Median: 1193.86 vs. THC: 28.85 )
THC' s 10-Year Shiller P/E Range
Min: 15.26   Max: 519
Current: 28.85

15.26
519
Current Ratio 1.34
THC's Current Ratio is ranked higher than
72% of the 306 Companies
in the Global Medical Care industry.

( Industry Median: 1.34 vs. THC: 1.34 )
THC' s 10-Year Current Ratio Range
Min: 0.92   Max: 2.38
Current: 1.34

0.92
2.38
Quick Ratio 1.25
THC's Quick Ratio is ranked higher than
73% of the 306 Companies
in the Global Medical Care industry.

( Industry Median: 1.21 vs. THC: 1.25 )
THC' s 10-Year Quick Ratio Range
Min: 0.87   Max: 2.29
Current: 1.25

0.87
2.29

Valuation & Return

vs
industry
vs
history
Price/Median PS Value 0.83
THC's Price/Median PS Value is ranked higher than
91% of the 326 Companies
in the Global Medical Care industry.

( Industry Median: 1.26 vs. THC: 0.83 )
THC' s 10-Year Price/Median PS Value Range
Min: 0.18   Max: 5.13
Current: 0.83

0.18
5.13
Earnings Yield (Greenblatt) 4.70
THC's Earnings Yield (Greenblatt) is ranked higher than
73% of the 302 Companies
in the Global Medical Care industry.

( Industry Median: 4.80 vs. THC: 4.70 )
THC' s 10-Year Earnings Yield (Greenblatt) Range
Min: 3.3   Max: 10.6
Current: 4.7

3.3
10.6
Forward Rate of Return (Yacktman) 10.02
THC's Forward Rate of Return (Yacktman) is ranked higher than
82% of the 246 Companies
in the Global Medical Care industry.

( Industry Median: 9.05 vs. THC: 10.02 )
THC' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -103.1   Max: 14.8
Current: 10.02

-103.1
14.8

Business Description

Industry: Health Care Providers » Medical Care
Compare:CHE, FMS, DVA, FSNUY, BDUUF » details
Traded in other countries:THC1.Germany
Tenet Healthcare Corporation, a Nevada corporation was incorporated in 1975. It is an investor-owned company whose subsidiaries and affiliates operate regionally focused, integrated health care delivery networks with a significant presence in several large urban and suburban markets. At the core of its networks are acute care and specialty hospitals that, together with its strategically aligned outpatient facilities and related businesses, allow them to provide a comprehensive range of health care services in the communities they serve. The Company primarily operated 77 hospitals, 183 outpatient centers, six health plans, six accountable care networks and Conifer Health Solutions, LLC ("Conifer"), which provides business process solutions to more than 700 hospital and other clients nationwide. It provides comprehensive operational management for revenue cycle functions, including patient access, health information management, revenue integrity and patient financial services. They also offer communications and engagement solutions to optimize the relationship between providers and patients. In addition, its management services offerings have expanded to support value-based performance through clinical integration, financial risk management and population health management. For financial reporting purposes, its business lines are classified into two separate reportable business segments — hospital operations and other, and Conifer. Its subsidiaries operated 77 hospitals, including four academic medical centers, two children's hospitals, three specialty hospitals and a critical access hospital, with a total of 20,293 licensed beds, serving primarily urban and suburban communities in 14 states. Of those hospitals, 72 were owned by its subsidiaries, and five were owned by third parties and leased by its subsidiaries. They are also in the process of constructing the new Resolute Health Hospital and Wellness Campus in New Braunfels, Texas, which is expected to be completed in or around May 2014. In addition, its subsidiaries operated a long-term acute care hospital and owned or leased and operated a number of medical office buildings, all of which were located on, or nearby, its hospital campuses. Furthermore, its subsidiaries operated 183 free-standing and provider-based outpatient centers in 16 states including diagnostic imaging centers, ambulatory surgery centers, urgent care centers and satellite emergency departments, among others. They also owned over 500 physician practices. Many of its hospitals also offer a wide range of clinical research studies, giving patients access to innovative care. The Company also own or control six accountable care networks — in Florida, California, Illinois, Michigan and Texas — and participate in two additional accountable care networks through collaborations with other health care providers in its markets in Arizona and Massachusetts. These networks operate using a range of payment and deliv

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK